Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder caused by deletions in the TSC1 or TSC2 genes that is associated with epilepsy in up to 90% of patients.
|
31761686 |
2019 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
LAM study: Effects of lacosamide on behaviour and quality of life in patients with epilepsy.
|
27993420 |
2019 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
They were diagnosed at an older age (p = 0.001), had more frequent normal cognition (p < 0.001) and less frequent epilepsy (p = 0.010), subependymal nodules (p = 0.022) and giant cell astrocytomas (p = 0.008) than patients with TSC2 pathogenic variants.
|
29432982 |
2018 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
To facilitate the development of mGluR5 treatment strategies, we tested the therapeutic utility of mGluR5 negative and positive allosteric modulators (an mGluR5 NAM and PAM) for TSC, using a mutant mouse model with neuronal loss of Tsc2 that demonstrates disease-related phenotypes, including behavioral symptoms of ASD and epilepsy.
|
29206810 |
2018 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Compared to patients with TSC1 mutations, individuals with TSC2 mutations had a significantly higher frequency of epilepsy (p<0.05) and tended to have a higher frequency of infantile spasms (37% vs 17%; p<0.3).
|
25498131 |
2014 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
As expected, TSC2 mutations were associated with a significantly higher occurrence of IS and other epilepsy types.
|
22867869 |
2013 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in TSC1 or TSC2 cause the tuberous sclerosis complex (TSC), a disorder characterised by the development of hamartomas or benign tumours in various organs as well as the variable presence of epilepsy, intellectual disability (ID) and autism.
|
23687350 |
2013 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, it is unknown if heterozygous germline mutations in TSC2 can produce the neurocognitive phenotype of TSC independent of epilepsy and tubers.
|
22189265 |
2012 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Learning and memory was unimpaired in naïve Tsc2 (+/-) rats, and experimental epilepsy did not impair any aspects of learning and memory in either wild-type or Tsc2 (+/-) rats.
|
20927644 |
2011 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Aberrant hyperactivation of mTOR as a consequence of loss-of-function gene mutations encoding mTOR inhibitor proteins such as TSC1, TSC2, PTEN and STRADα has been recently linked to developmental cortical malformations associated with epilepsy and neurobehavioral disabilities.
|
21890410 |
2011 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
CTD_human |
Similar to Tsc1(GFAP1)CKO mice, Tsc2(GFAP1)CKO mice exhibited epilepsy, premature death, progressive megencephaly, diffuse glial proliferation, dispersion of hippocampal pyramidal cells and decreased astrocyte glutamate transporter expression.
|
21062901 |
2011 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
|
19332694 |
2009 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Tuberous sclerosis (TSC) is a multi-system disorder caused by heterozygous mutations in the TSC1 or TSC2 gene and is often associated with neuropsychiatric symptoms, including intellectual disability, specific neuropsychological deficits, autism, other behavioural disorders and epilepsy.
|
19694899 |
2009 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Previous studies revealed different alterations of TSC1 and TSC2 in epilepsy-associated malformations and glio-neuronal tumors despite histopathologic similarities.
|
16042315 |
2005 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The study of the molecular pathogenesis of epilepsy in tuberous sclerosis has taken on a new dimension with the identification of the TSC1 and TSC2 genes.
|
12040899 |
2002 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The data demonstrate numerous polymorphisms as well as a novel TSC2 mutation in gangliogliomas from patients with chronic epilepsies.
|
11437991 |
2001 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Studies of how TSC1 and TSC2 function in normal and dysplastic cerebral neocortex may provide a paradigm for understanding the neurobiology of other genes that determine epilepsy-associated cerebral malformations (e.g. lissencephaly, double cortex).
|
9761305 |
1998 |